SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
AXGN

Axogen, Inc. (NASDAQ:AXGN)

US · Delayed Price · Currency is USD
Also listed: 0HKD.LHealthcare · Medical - Devices
$55.75-$0.60 (-1.06%)
 
Market cap
$3.33B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 17, 1986
Market Cap$3.33B+96.4%
Revenue (ttm)$266.93M+24.3%
Net Income-$31.92M-1422.3%
EPS-$0.65-1229.2%
Shares Out59.73M
PE Ration/a
Forward PE79.01
Dividendn/a
Ex-Dividend DateJan 27, 2010
Volume876,067
Open$55.71
Previous Close$56.35
Day's Range$55.03 - $56.91
52-Week Range$26.92 - $59.72
Beta1.15
AnalystsBuy
Price Target$58.13(+4.27%)
Earnings DateFeb 23, 2027

About AXGN

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.

Address
13631 Progress Boulevard, Alachua, FL, 32615, US
Market Cap
3.33 billion
Employees
622
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$6.31M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
7 Buy0 Hold0 SellAvg target $54.00 (-3.1%)

7 firms rating AXGN in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From AXGN’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.06%
5 Days
+0.34%
1 Month
+51.99%
6 Months
+36.31%
1 Year
+96.37%

$AXGN stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of AXGN by members of U.S. Congress

Donna ShalalaHouseSale$1.00K – $15.00KJun 24, 2019
Donna ShalalaHousePurchase$1.00K – $15.00KApr 16, 2019

Recently reported changes in AXGN holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by AXGN's directors and management

Net Shares Purchased by Insiders−100k−50k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

AXGN Estimated quarterly lobbying spending

Source: U.S. Senate LDA

AXGN Revenue by Segment or Geography

AXGN's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New AXGN patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to AXGN from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in AXGN

IWMiShares Russell 2000 ETF$79.81M
VTIVanguard Morningstar Total Stock Market ETF$67.06M
VXFVanguard Extended Market ETF$32.93M
IWOiShares Russell 2000 Growth ETF$28.33M
SCHASchwab U.S. Small-Cap ETF$17.20M
IHIiShares U.S. Medical Devices ETF$16.44M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from AXGN’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
93
News & Sentiment
20% of score
55

News check: Mixed coverage with neutral momentum discussion offset by valuation concerns; no analyst actions or earnings catalysts reported.

Recent Insider Activity

Buys
0
Sells
11
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-35.0 since Aug 21
0255075100Aug 21 — Insider Score 35.0Aug 22 — Insider Score 35.0Aug 23 — Insider Score 35.0Aug 24 — Insider Score 35.0Aug 25 — Insider Score 35.0Aug 26 — Insider Score 35.0Aug 27 — Insider Score 35.0Aug 28 — Insider Score 35.0Aug 29 — Insider Score 35.0Aug 30 — Insider Score 35.0Aug 31 — Insider Score 35.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 23.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

IBRNiShares Neuroscience and Healthcare ETF4.28%
PTHInvesco Dorsey Wright Healthcare Momentum ETF3.19%
HTECROBO Global Healthcare Technology and Innovation ETF2.20%
XHEState Street SPDR S&P Health Care Equipment ETF1.78%
SAWSAAM Sawgrass U.S. Small Cap Quality Growth ETF1.24%
CTAGCalamos Timpani Active SMID Growth ETF1.06%
FESCFirst Eagle Small Cap Equity ETF0.72%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF0.71%
FTKIFirst Trust Small Cap BuyWrite Income ETF0.68%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.59%
FYCFirst Trust Small Cap Growth AlphaDEX Fund0.51%
EHLSEven Herd Long Short ETF0.50%

Weight is the stock’s share of each fund’s holdings.